1-[4-[6-(1H-benzimidazol-2-ylmethylamino)-9-thiophen-3-ylpurin-2-yl]phenyl]-2-cyclopropylethanone;N-(1H-benzimidazol-2-ylmethyl)-2-morpholin-4-yl-9-phenylpurin-6-amine;6-N-(1H-benzimidazol-2-ylmethyl)-9-propan-2-yl-2-N-pyrimidin-4-ylpurine-2,6-diamine;N-(1H-benzimidazol-2-ylmethyl)-2-(4-pyridin-2-ylpiperazin-1-yl)-9-thiophen-3-ylpurin-6-amine

C97H89N35O2S2 — CID 158997872

IUPAC1-[4-[6-(1H-benzimidazol-2-ylmethylamino)-9-thiophen-3-ylpurin-2-yl]phenyl]-2-cyclopropylethanone;N-(1H-benzimidazol-2-ylmethyl)-2-morpholin-4-yl-9-phenylpurin-6-amine;6-N-(1H-benzimidazol-2-ylmethyl)-9-propan-2-yl-2-N-pyrimidin-4-ylpurine-2,6-diamine;N-(1H-benzimidazol-2-ylmethyl)-2-(4-pyridin-2-ylpiperazin-1-yl)-9-thiophen-3-ylpurin-6-amine
SMILESCC(C)n1cnc2c(NCc3nc4ccccc4[nH]3)nc(Nc3ccncn3)nc21.O=C(CC1CC1)c1ccc(-c2nc(NCc3nc4ccccc4[nH]3)c3ncn(-c4ccsc4)c3n2)cc1.c1ccc(-n2cnc3c(NCc4nc5ccccc5[nH]4)nc(N4CCOCC4)nc32)cc1.c1ccc(N2CCN(c3nc(NCc4nc5ccccc5[nH]4)c4ncn(-c5ccsc5)c4n3)CC2)nc1
InChIInChI=1S/C28H23N7OS.C26H24N10S.C23H22N8O.C20H20N10/c36-23(13-17-5-6-17)18-7-9-19(10-8-18)26-33-27(29-14-24-31-21-3-1-2-4-22(21)32-24)25-28(34-26)35(16-30-25)20-11-12-37-15-20;1-2-6-20-19(5-1)30-21(31-20)15-28-24-23-25(36(17-29-23)18-8-14-37-16-18)33-26(32-24)35-12-10-34(11-13-35)22-7-3-4-9-27-22;1-2-6-16(7-3-1)31-15-25-20-21(24-14-19-26-17-8-4-5-9-18(17)27-19)28-23(29-22(20)31)30-10-12-32-13-11-30;1-12(2)30-11-24-17-18(22-9-16-25-13-5-3-4-6-14(13)26-16)28-20(29-19(17)30)27-15-7-8-21-10-23-15/h1-4,7-12,15-17H,5-6,13-14H2,(H,31,32)(H,29,33,34);1-9,14,16-17H,10-13,15H2,(H,30,31)(H,28,32,33);1-9,15H,10-14H2,(H,26,27)(H,24,28,29);3-8,10-12H,9H2,1-2H3,(H,25,26)(H2,21,22,23,27,28,29)
InChIKeyJQYWDWPTPRNNFD-UHFFFAOYSA-N
MW1841.16 g/mol
LogP16.67
Rot. Bonds25

About 1-[4-[6-(1H-benzimidazol-2-ylmethylamino)-9-thiophen-3-ylpurin-2-yl]phenyl]-2-cyclopropylethanone;N-(1H-benzimidazol-2-ylmethyl)-2-morpholin-4-yl-9-phenylpurin-6-amine;6-N-(1H-benzimidazol-2-ylmethyl)-9-propan-2-yl-2-N-pyrimidin-4-ylpurine-2,6-diamine;N-(1H-benzimidazol-2-ylmethyl)-2-(4-pyridin-2-ylpiperazin-1-yl)-9-thiophen-3-ylpurin-6-amine

1-[4-[6-(1H-benzimidazol-2-ylmethylamino)-9-thiophen-3-ylpurin-2-yl]phenyl]-2-cyclopropylethanone;N-(1H-benzimidazol-2-ylmethyl)-2-morpholin-4-yl-9-phenylpurin-6-amine;6-N-(1H-benzimidazol-2-ylmethyl)-9-propan-2-yl-2-N-pyrimidin-4-ylpurine-2,6-diamine;N-(1H-benzimidazol-2-ylmethyl)-2-(4-pyridin-2-ylpiperazin-1-yl)-9-thiophen-3-ylpurin-6-amine (PubChem CID 158997872) has the molecular formula C97H89N35O2S2 and a molecular weight of 1841.16 g/mol. Its IUPAC name is 1-[4-[6-(1H-benzimidazol-2-ylmethylamino)-9-thiophen-3-ylpurin-2-yl]phenyl]-2-cyclopropylethanone;N-(1H-benzimidazol-2-ylmethyl)-2-morpholin-4-yl-9-phenylpurin-6-amine;6-N-(1H-benzimidazol-2-ylmethyl)-9-propan-2-yl-2-N-pyrimidin-4-ylpurine-2,6-diamine;N-(1H-benzimidazol-2-ylmethyl)-2-(4-pyridin-2-ylpiperazin-1-yl)-9-thiophen-3-ylpurin-6-amine.

Molecular Properties

Compound Name1-[4-[6-(1H-benzimidazol-2-ylmethylamino)-9-thiophen-3-ylpurin-2-yl]phenyl]-2-cyclopropylethanone;N-(1H-benzimidazol-2-ylmethyl)-2-morpholin-4-yl-9-phenylpurin-6-amine;6-N-(1H-benzimidazol-2-ylmethyl)-9-propan-2-yl-2-N-pyrimidin-4-ylpurine-2,6-diamine;N-(1H-benzimidazol-2-ylmethyl)-2-(4-pyridin-2-ylpiperazin-1-yl)-9-thiophen-3-ylpurin-6-amine
PubChem CID158997872
Molecular FormulaC97H89N35O2S2
Molecular Weight1841.16 g/mol
Exact Mass1839.74
IUPAC Name1-[4-[6-(1H-benzimidazol-2-ylmethylamino)-9-thiophen-3-ylpurin-2-yl]phenyl]-2-cyclopropylethanone;N-(1H-benzimidazol-2-ylmethyl)-2-morpholin-4-yl-9-phenylpurin-6-amine;6-N-(1H-benzimidazol-2-ylmethyl)-9-propan-2-yl-2-N-pyrimidin-4-ylpurine-2,6-diamine;N-(1H-benzimidazol-2-ylmethyl)-2-(4-pyridin-2-ylpiperazin-1-yl)-9-thiophen-3-ylpurin-6-amine
SMILESCC(C)n1cnc2c(NCc3nc4ccccc4[nH]3)nc(Nc3ccncn3)nc21.O=C(CC1CC1)c1ccc(-c2nc(NCc3nc4ccccc4[nH]3)c3ncn(-c4ccsc4)c3n2)cc1.c1ccc(-n2cnc3c(NCc4nc5ccccc5[nH]4)nc(N4CCOCC4)nc32)cc1.c1ccc(N2CCN(c3nc(NCc4nc5ccccc5[nH]4)c4ncn(-c5ccsc5)c4n3)CC2)nc1
InChIInChI=1S/C28H23N7OS.C26H24N10S.C23H22N8O.C20H20N10/c36-23(13-17-5-6-17)18-7-9-19(10-8-18)26-33-27(29-14-24-31-21-3-1-2-4-22(21)32-24)25-28(34-26)35(16-30-25)20-11-12-37-15-20;1-2-6-20-19(5-1)30-21(31-20)15-28-24-23-25(36(17-29-23)18-8-14-37-16-18)33-26(32-24)35-12-10-34(11-13-35)22-7-3-4-9-27-22;1-2-6-16(7-3-1)31-15-25-20-21(24-14-19-26-17-8-4-5-9-18(17)27-19)28-23(29-22(20)31)30-10-12-32-13-11-30;1-12(2)30-11-24-17-18(22-9-16-25-13-5-3-4-6-14(13)26-16)28-20(29-19(17)30)27-15-7-8-21-10-23-15/h1-4,7-12,15-17H,5-6,13-14H2,(H,31,32)(H,29,33,34);1-9,14,16-17H,10-13,15H2,(H,30,31)(H,28,32,33);1-9,15H,10-14H2,(H,26,27)(H,24,28,29);3-8,10-12H,9H2,1-2H3,(H,25,26)(H2,21,22,23,27,28,29)
InChIKeyJQYWDWPTPRNNFD-UHFFFAOYSA-N
XLogP16.67
TPSA423.96 Ų
H-Bond Donors9
H-Bond Acceptors35
Rotatable Bonds25
Heavy Atoms136
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001841.16
LogP ≤ 516.67
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1035

Analyze 1-[4-[6-(1H-benzimidazol-2-ylmethylamino)-9-thiophen-3-ylpurin-2-yl]phenyl]-2-cyclopropylethanone;N-(1H-benzimidazol-2-ylmethyl)-2-morpholin-4-yl-9-phenylpurin-6-amine;6-N-(1H-benzimidazol-2-ylmethyl)-9-propan-2-yl-2-N-pyrimidin-4-ylpurine-2,6-diamine;N-(1H-benzimidazol-2-ylmethyl)-2-(4-pyridin-2-ylpiperazin-1-yl)-9-thiophen-3-ylpurin-6-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[4-[6-(1H-benzimidazol-2-ylmethylamino)-9-thiophen-3-ylpurin-2-yl]phenyl]-2-cyclopropylethanone;N-(1H-benzimidazol-2-ylmethyl)-2-morpholin-4-yl-9-phenylpurin-6-amine;6-N-(1H-benzimidazol-2-ylmethyl)-9-propan-2-yl-2-N-pyrimidin-4-ylpurine-2,6-diamine;N-(1H-benzimidazol-2-ylmethyl)-2-(4-pyridin-2-ylpiperazin-1-yl)-9-thiophen-3-ylpurin-6-amine?
The IUPAC name of 1-[4-[6-(1H-benzimidazol-2-ylmethylamino)-9-thiophen-3-ylpurin-2-yl]phenyl]-2-cyclopropylethanone;N-(1H-benzimidazol-2-ylmethyl)-2-morpholin-4-yl-9-phenylpurin-6-amine;6-N-(1H-benzimidazol-2-ylmethyl)-9-propan-2-yl-2-N-pyrimidin-4-ylpurine-2,6-diamine;N-(1H-benzimidazol-2-ylmethyl)-2-(4-pyridin-2-ylpiperazin-1-yl)-9-thiophen-3-ylpurin-6-amine (CID 158997872) is 1-[4-[6-(1H-benzimidazol-2-ylmethylamino)-9-thiophen-3-ylpurin-2-yl]phenyl]-2-cyclopropylethanone;N-(1H-benzimidazol-2-ylmethyl)-2-morpholin-4-yl-9-phenylpurin-6-amine;6-N-(1H-benzimidazol-2-ylmethyl)-9-propan-2-yl-2-N-pyrimidin-4-ylpurine-2,6-diamine;N-(1H-benzimidazol-2-ylmethyl)-2-(4-pyridin-2-ylpiperazin-1-yl)-9-thiophen-3-ylpurin-6-amine.
What is the SMILES notation for 1-[4-[6-(1H-benzimidazol-2-ylmethylamino)-9-thiophen-3-ylpurin-2-yl]phenyl]-2-cyclopropylethanone;N-(1H-benzimidazol-2-ylmethyl)-2-morpholin-4-yl-9-phenylpurin-6-amine;6-N-(1H-benzimidazol-2-ylmethyl)-9-propan-2-yl-2-N-pyrimidin-4-ylpurine-2,6-diamine;N-(1H-benzimidazol-2-ylmethyl)-2-(4-pyridin-2-ylpiperazin-1-yl)-9-thiophen-3-ylpurin-6-amine?
The canonical SMILES for 1-[4-[6-(1H-benzimidazol-2-ylmethylamino)-9-thiophen-3-ylpurin-2-yl]phenyl]-2-cyclopropylethanone;N-(1H-benzimidazol-2-ylmethyl)-2-morpholin-4-yl-9-phenylpurin-6-amine;6-N-(1H-benzimidazol-2-ylmethyl)-9-propan-2-yl-2-N-pyrimidin-4-ylpurine-2,6-diamine;N-(1H-benzimidazol-2-ylmethyl)-2-(4-pyridin-2-ylpiperazin-1-yl)-9-thiophen-3-ylpurin-6-amine is CC(C)n1cnc2c(NCc3nc4ccccc4[nH]3)nc(Nc3ccncn3)nc21.O=C(CC1CC1)c1ccc(-c2nc(NCc3nc4ccccc4[nH]3)c3ncn(-c4ccsc4)c3n2)cc1.c1ccc(-n2cnc3c(NCc4nc5ccccc5[nH]4)nc(N4CCOCC4)nc32)cc1.c1ccc(N2CCN(c3nc(NCc4nc5ccccc5[nH]4)c4ncn(-c5ccsc5)c4n3)CC2)nc1.
What is the InChIKey of 1-[4-[6-(1H-benzimidazol-2-ylmethylamino)-9-thiophen-3-ylpurin-2-yl]phenyl]-2-cyclopropylethanone;N-(1H-benzimidazol-2-ylmethyl)-2-morpholin-4-yl-9-phenylpurin-6-amine;6-N-(1H-benzimidazol-2-ylmethyl)-9-propan-2-yl-2-N-pyrimidin-4-ylpurine-2,6-diamine;N-(1H-benzimidazol-2-ylmethyl)-2-(4-pyridin-2-ylpiperazin-1-yl)-9-thiophen-3-ylpurin-6-amine?
The InChIKey is JQYWDWPTPRNNFD-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H23N7OS.C26H24N10S.C23H22N8O.C20H20N10/c36-23(13-17-5-6-17)18-7-9-19(10-8-18)26-33-27(29-14-24-31-21-3-1-2-4-22(21)32-24)25-28(34-26)35(16-30-25)20-11-12-37-15-20;1-2-6-20-19(5-1)30-21(31-20)15-28-24-23-25(36(17-29-23)18-8-14-37-16-18)33-26(32-24)35-12-10-34(11-13-35)22-7-3-4-9-27-22;1-2-6-16(7-3-1)31-15-25-20-21(24-14-19-26-17-8-4-5-9-18(17)27-19)28-23(29-22(20)31)30-10-12-32-13-11-30;1-12(2)30-11-24-17-18(22-9-16-25-13-5-3-4-6-14(13)26-16)28-20(29-19(17)30)27-15-7-8-21-10-23-15/h1-4,7-12,15-17H,5-6,13-14H2,(H,31,32)(H,29,33,34);1-9,14,16-17H,10-13,15H2,(H,30,31)(H,28,32,33);1-9,15H,10-14H2,(H,26,27)(H,24,28,29);3-8,10-12H,9H2,1-2H3,(H,25,26)(H2,21,22,23,27,28,29).
What are the key properties of 1-[4-[6-(1H-benzimidazol-2-ylmethylamino)-9-thiophen-3-ylpurin-2-yl]phenyl]-2-cyclopropylethanone;N-(1H-benzimidazol-2-ylmethyl)-2-morpholin-4-yl-9-phenylpurin-6-amine;6-N-(1H-benzimidazol-2-ylmethyl)-9-propan-2-yl-2-N-pyrimidin-4-ylpurine-2,6-diamine;N-(1H-benzimidazol-2-ylmethyl)-2-(4-pyridin-2-ylpiperazin-1-yl)-9-thiophen-3-ylpurin-6-amine?
1-[4-[6-(1H-benzimidazol-2-ylmethylamino)-9-thiophen-3-ylpurin-2-yl]phenyl]-2-cyclopropylethanone;N-(1H-benzimidazol-2-ylmethyl)-2-morpholin-4-yl-9-phenylpurin-6-amine;6-N-(1H-benzimidazol-2-ylmethyl)-9-propan-2-yl-2-N-pyrimidin-4-ylpurine-2,6-diamine;N-(1H-benzimidazol-2-ylmethyl)-2-(4-pyridin-2-ylpiperazin-1-yl)-9-thiophen-3-ylpurin-6-amine has a molecular weight of 1841.16 g/mol, XLogP of 16.67, 25 rotatable bonds, 9 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[4-[6-(1H-benzimidazol-2-ylmethylamino)-9-thiophen-3-ylpurin-2-yl]phenyl]-2-cyclopropylethanone;N-(1H-benzimidazol-2-ylmethyl)-2-morpholin-4-yl-9-phenylpurin-6-amine;6-N-(1H-benzimidazol-2-ylmethyl)-9-propan-2-yl-2-N-pyrimidin-4-ylpurine-2,6-diamine;N-(1H-benzimidazol-2-ylmethyl)-2-(4-pyridin-2-ylpiperazin-1-yl)-9-thiophen-3-ylpurin-6-amine is sourced from PubChem (CID 158997872), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).